Management of known risk factors should reduce the risk of acute pancreatitis. Eating a balanced, low-fat diet, maintaining adequate triglyceride control, and reducing alcohol intake may help decrease the incidence of pancreatitis.
The use of peri-ERCP rectal indomethacin has been established as a standard of care in decreasing the risk of severe acute post-ERCP pancreatitis.[33]Akshintala VS, Sperna Weiland CJ, Bhullar FA, et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021 Sep;6(9):733-42.
http://www.ncbi.nlm.nih.gov/pubmed/34214449?tool=bestpractice.com
[34]Márta K, Gede N, Szakács Z, et al. Combined use of indomethacin and hydration is the best conservative approach for post-ERCP pancreatitis prevention: a network meta-analysis. Pancreatology. 2021 Oct;21(7):1247-55.
https://www.sciencedirect.com/science/article/pii/S1424390321004993
http://www.ncbi.nlm.nih.gov/pubmed/34353727?tool=bestpractice.com
[35]Buxbaum JL, Freeman M, Amateau SK, et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023 Feb;97(2):153-62.
http://www.ncbi.nlm.nih.gov/pubmed/36517310?tool=bestpractice.com
[44]Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020 Feb;52(2):127-49.
https://www.doi.org/10.1055/a-1075-4080
http://www.ncbi.nlm.nih.gov/pubmed/31863440?tool=bestpractice.com
There is also evidence to show that intravenous hydration with 1-3 L of Ringer lactate (Hartmann solution) either before, during, or after the procedure can lead to a significant decrease in the incidence of post-ERCP pancreatitis.[35]Buxbaum JL, Freeman M, Amateau SK, et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023 Feb;97(2):153-62.
http://www.ncbi.nlm.nih.gov/pubmed/36517310?tool=bestpractice.com
[44]Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020 Feb;52(2):127-49.
https://www.doi.org/10.1055/a-1075-4080
http://www.ncbi.nlm.nih.gov/pubmed/31863440?tool=bestpractice.com
[45]Buxbaum J, Yan A, Yeh K, et al. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014 Feb;12(2):303-7.e1.
https://www.cghjournal.org/article/S1542-3565(13)01090-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/23920031?tool=bestpractice.com
[46]Wu D, Wan J, Xia L, et al. The efficiency of aggressive hydration with lactated ringer solution for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. J Clin Gastroenterol. 2017 Sep;51(8):e68-76.
http://www.ncbi.nlm.nih.gov/pubmed/28609383?tool=bestpractice.com
The use of pancreatic duct stents is recommended for selected high risk patients to reduce the risk of severe pancreatitis following ERCP.[33]Akshintala VS, Sperna Weiland CJ, Bhullar FA, et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021 Sep;6(9):733-42.
http://www.ncbi.nlm.nih.gov/pubmed/34214449?tool=bestpractice.com
[35]Buxbaum JL, Freeman M, Amateau SK, et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023 Feb;97(2):153-62.
http://www.ncbi.nlm.nih.gov/pubmed/36517310?tool=bestpractice.com
[44]Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020 Feb;52(2):127-49.
https://www.doi.org/10.1055/a-1075-4080
http://www.ncbi.nlm.nih.gov/pubmed/31863440?tool=bestpractice.com
For patients with Sphincter of Oddi dysfunction (SOD), ERCP with a sphincterotomy may relieve the mechanical obstruction responsible for pain and pancreatitis; conversely it may precipitate acute pancreatitis, and its use in individuals with idiopathic pancreatitis (and/or chronic pain) should be limited to those with a high likelihood of SOD (e.g., abnormal imaging and abnormal liver function tests).[39]Guda NM, Muddana V, Whitcomb DC, et al. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas. 2018 Jul;47(6):653-66.
http://www.ncbi.nlm.nih.gov/pubmed/29894415?tool=bestpractice.com